Youtube
BALAXI

Balaxi Pharmaceuticals Ltd..

₹413.95

Score

31

Technically Bearish

Balaxi Pharmaceuticals Price Change Analysis

Balaxi Pharmaceuticals Key Statistics
  • P/E Ratio

    29.1

  • PEG Ratio

    0.3

  • Market Cap Cr

    414

  • Price to Book Ratio

    57.9

  • EPS

    14.7

  • Dividend

    5 ()

  • Relative Strength Index

    50

  • Money Flow Index

    68.54

  • MACD Signal

    0.63

  • Average True Range

    37.9

Investment Ratings

  • Master Rating:

EPS Strength

Price Strength

Buyer Demand

Group Rank

Result Highlights

Balaxi Pharmaceuticals Synopsis

NSE-Medical-Generic Drugs

Balaxi Pharmaceutica is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 86.87 Cr. and Equity Capital is Rs. 10.00 Cr. for the Year ended 31/03/2021. Balaxi Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 28/09/1942 and has its registered office in the State of Kerala, India. Company’s Corporate Identification Number(CIN) is L25191TG1942PLC121598 and registration number is 000045.
  • Market Cap

    414.30

  • Sales

    101.29

  • Shares in Float

    0.27

  • No of Funds

    4

  • Yield

  • Book Value

    9.86

  • U/D Vol Ratio

    2.5

  • LTDebt/Equity

  • Alpha

    -0.18

  • Beta

    0.92

Balaxi Pharmaceuticals Ownership
Balaxi Pharmaceuticals Management

Balaxi Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Eps And Sales Estimates

Balaxi Pharmaceuticals Financials

Balaxi Pharmaceuticals Technicals

EMA & SMA

CURRENT PRICE

EMA

Balaxi Pharmaceuticals Resistance and Support

Balaxi Pharmaceuticals Delivery and Volume

Balaxi Pharmaceuticals Price Change Analysis

Corporate Action

MF Shareholding

Similar Stocks

Videos

About Company

News

FAQs

Balaxi Pharmaceuticals share price is

Open Demat Account